Active Emergence From General Anesthesia Clinical Trial
Official title:
Electroencephalogram Studies of Intravenous Methylphenidate-Induced Emergence From General Anesthesia
Verified date | August 2017 |
Source | Massachusetts General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to test the hypothesis that methylphenidate actively induces emergence from propofol and sevoflurane general anesthesia in healthy volunteers.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2019 |
Est. primary completion date | July 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 36 Years |
Eligibility |
Inclusion Criteria: 1. Age 18-36 years 2. ASA classification 1 or 2 3. Normal body weight, BMI = 30 4. Non-smoker 5. Right handed 6. No history of taking stimulants Exclusion Criteria: - In general, patients will be excluded from the study if the state of their chronic health problems gives them an ASA physical status classification of 3 or beyond. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Response to methlyphenidate administration | The number of minutes from the administration of methylphenidate until subjects respond to verbal commands | minutes to response, expected average is less than 10 minutes |